A61K 31/603
Having further aromatic rings
Official title: having further aromatic rings, e.g. diflunisal
A61K31/603 (Having further aromatic rings) appears on 59 US grants and 112 published applications in this corpus.
Search patents in A61K- Granted patents
- 59
- Published applications
- 112
- Assignees
- 63
- Inventors
- 204
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 2 | 4 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 2 | 7 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 3 | 1 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 1 | 6 |
| 2015 | 4 | 6 |
| 2016 | 0 | 11 |
| 2017 | 9 | 6 |
| 2018 | 4 | 3 |
| 2019 | 4 | 8 |
| 2020 | 5 | 10 |
| 2021 | 2 | 9 |
| 2022 | 5 | 8 |
| 2023 | 2 | 3 |
| 2024 | 1 | 6 |
| 2025 | 5 | 4 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for preventing and/or treating filarial disease9 Jun 2026US 12,648,929 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Therapy19 May 2026US 12,629,382 B2Vestlandets Innovasjonsselskap AS
- Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability9 Dec 2025US 12,491,207 B2Vaneltix Pharma, Inc.
- Methods and compositions to inhibit dependence on opioids22 Apr 2025US 12,280,028 B2Sen-Jam Pharmaceutical LLC
- Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent8 Apr 2025US 12,268,669 B2Pfizer Inc.
- Composition for treating cancer cachexia, comprising diflunisal or a pharmaceutically acceptable salt thereof6 Aug 2026US 2026/0224594 A1
- Treatment of myeloperoxidase-positive anca-associated vasculitis with h2s releasing compounds30 Jul 2026US 2026/0216220 A1Debreceni Egyetem
- Methods of treating lipedema including akr1c1 as a therapeutic target25 Jun 2026US 2026/0174776 A1Magi Euregio Scs
- Compositions and methods for treating transthyretin (ttr) mediated amyloidosis26 Feb 2026US 2026/0053839 A1Alnylam Pharmaceuticals, Inc.
- Combination of a ketone body or ketogenic compound with an analgesic or antioxidant4 Sep 2025US 2025/0275986 A1Ketoswiss AG
Most cited
By later US patents
- Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs44US 6,368,618 B1University of Georgia Research Foundation, Inc. · 2002
- Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light21US 6,843,961 B2Gambro AB · 2005
- Method of treating colonic adenomas14US 5,968,974 AMerck & Co., Inc. · 1999
- Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof11US 7,011,854 B2ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. · 2006
- Methods and reagents for the treatment of metabolic disorders10US 7,795,310 B2CombinatoRx, Incorporated · 2010